Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8 Billion

Eli Lilly announced its intention to acquire Centessa Pharmaceuticals for up to $7.8 billion, a deal aimed at bolstering its portfolio of sleep medicines and narcolepsy drugs, with the acquisition expected to close in the third quarter. Reports indicate the deal could be valued at $6.3 billion or up to $7.8 billion.

31 Mar, 12:32 — 31 Mar, 15:26

Post Share

Why this matters

This acquisition signifies Eli Lilly's strategic move to expand its pipeline in sleep disorder treatments, a growing market with significant unmet needs. It highlights the pharmaceutical industry's focus on innovative therapies for conditions like narcolepsy.

Key entitiesEli Lilly Centessa Pharmaceuticals

The Story

What 7 sources agree on, dispute, and miss

What sources agree on

Eli Lilly will acquire Centessa Pharmaceuticals
The acquisition is valued at up to $7.8 billion
Centessa Pharmaceuticals develops experimental drugs for sleep disorders, specifically narcolepsy

Key claims3 agreed · 2 unverified

✓

Eli Lilly plans to acquire Centessa Pharmaceuticals

agreed·NYTcnbcReutersdie-pressebloomberg

✓

The acquisition is for up to $7.8 billion

agreed·cnbcReutersdie-pressebloomberg

The acquisition is for $6.3 billion

unverified·NYT

✓

Centessa is developing drugs to treat narcolepsy

agreed·NYTcnbc

The acquisition is expected to close in the third quarter

unverified·die-presse

Coverage gaps

The expected completion timeframe for the acquisition (third quarter)

Reporteddie-presse

MissingNYTcnbcReuters+1

Centessa's lead drug is in a midstage clinical trial

ReportedNYT

MissingcnbcReutersdie-presse+1

The Story

Analyzing sources…

Source Diversity

High (71/100)

7 sources33/33

Spectrum spread— 4/5 buckets covered25/33

Far L1

Far Left (1)

NYT

Left2

Left (2)

Yahoocnbc

Center3

Center (3)

Reutersmarketwatchbloomberg

Right1

Right (1)

die-presse

Far R

Geographic diversity— 3 regions13/34

US5Intl1Austria1

Political spectrum

LeftCenterRight

nytimes

cnbc

reuters

bloomberg

die-presse

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

NYTcenter-leftcenter-leftneutralMostly FactualFocus on drug development stage and value

cnbccentercenter-leftanalyticalMostly FactualEmphasis on financial value and drug class

Coverage leans: balanced

The coverage is largely neutral and factual, focusing on the financial details and the pharmaceutical implications of the acquisition, without significant political framing.

Sources

Showing 5 of 7 sources

ReutersVery High7h ago

Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet - Reuters

Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet Reuters

Read full article →

NYTMostly Factual5h ago

Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.

By Rebecca Robbins

Read full article →

cnbcMostly Factual5h ago

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.

Read full article →

marketwatchMostly Factual7h ago

Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

The company, which is flush with cash from sales of its market-leading GLP-1 franchise, has been an active dealmaker.

By Jaimy Lee

Read full article →

YahooMostly Factual4h ago

Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio

Read full article →

Coverage Timeline

First report: bloomberg · 31 Mar, 11:22|Full coverage: 7 · 4h|Window: 4h

Left-leaningCenterRight-leaning

bloomberg31 Mar, 11:22First to report

Eli Lilly to Buy Centessa Pharmaceuticals for Up to $7.8 Billion - Bloomberg.com

die-presse31 Mar, 12:02

Eli Lilly übernimmt Schlafmittel-Firma Centessa für Milliarden

marketwatch31 Mar, 12:32

Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

Reuters31 Mar, 12:39

Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet - Reuters

2h later

cnbc31 Mar, 14:46

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

NYT31 Mar, 14:49

Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Yahoo31 Mar, 15:26Latest update

Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio

Story evolution

Initial ReportsMarch 31 morning

Bloomberg and Die Presse first reported the acquisition and the 'up to $7.8 billion' valuation.

Confirmation and DetailsMarch 31 afternoon

Reuters, CNBC, and NYT confirmed the deal, adding details about Centessa's drug focus and clinical trial status.

Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8 Billion

Why this matters

The Story

What sources agree on

Key claims3 agreed · 2 unverified

Coverage gaps

The Story

Source Diversity

Source Diversity

Political spectrum

Sources

Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet - Reuters

Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio

Coverage Timeline

Eli Lilly to Buy Centessa Pharmaceuticals for Up to $7.8 Billion - Bloomberg.com

Eli Lilly übernimmt Schlafmittel-Firma Centessa für Milliarden

Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet - Reuters

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio

Story evolution

Related Stories

11-Year-Old Asks Philippine President Marcos Jr. About Sexual Injustices

Lawsuit Alleges Negligence Led to Patient Killing Roommate at Minnesota Mental Health Facility

New Nursing Home Beds Open in Kópavogur, Iceland, to Ease Healthcare Strain

Explosion at Illegal Firecracker Unit in Ludhiana Kills One, Injures Two

Why this matters

Story evolution

The Story

What sources agree on

Key claims3 agreed · 2 unverified

Coverage gaps

Coverage matrix

Political spectrum